Genetic drift of parvovirus B19 is found in AIDS patients with persistent B19 infection

Chien-Ching Hung1, Wang-Hwei Sheng, Kuang-Lun Lee

  • 1Department of Internal Medicine, Section of Infectious Disease, National Taiwan University Hospital, Taipei, Taiwan.

Journal of Medical Virology
|September 26, 2006
PubMed

Insights

Parvovirus B19 is generally stable, but persistent infections in AIDS patients show genetic changes. Highly active anti-retroviral therapy (HAART) correlates with parvovirus B19 genetic drift.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Parvovirus B19 is typically considered genetically stable, with no prior evidence of genetic drift in persistent infections.
  • Persistent parvovirus B19 infection is a concern in immunocompromised individuals, such as those with Acquired Immunodeficiency Syndrome (AIDS).

Observation:

  • This study investigated longitudinal genetic changes in parvovirus B19 NS1 and VP1 genes from three AIDS patients with persistent B19 infection.
  • One patient received no highly active anti-retroviral therapy (HAART), while two others received HAART, with one experiencing treatment failure and subsequent mega-HAART.
  • B19 viral DNA was amplified using polymerase chain reaction (PCR) and directly sequenced.

Findings:

  • A single genetic change was observed in the B19 isolate from the untreated patient post-intravenous immunoglobulin (IVIG) treatment, with subsequent stability over 11 months.
  • Analysis of NS1 clones revealed quasi-species but no genetic drift in the untreated patient.
  • In contrast, multiple genetic changes and confirmed genetic drift were observed in B19 isolates from the two HAART-treated patients, particularly after HAART and mega-HAART interventions.
  • Non-conserved nucleotide substitutions in the VP2 gene of drifting isolates suggest positive selection.

Implications:

  • The findings challenge the notion of parvovirus B19's universal genetic stability, especially in the context of persistent infections and specific therapeutic interventions.
  • Highly active anti-retroviral therapy (HAART) and related treatments may influence the genetic evolution of parvovirus B19 in AIDS patients.
  • Understanding these genetic dynamics is crucial for managing persistent parvovirus B19 infections and developing effective treatment strategies in immunocompromised populations.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Genetic Drift03:33

Genetic Drift

Natural selection—probably the most well-known evolutionary mechanism—increases the prevalence of traits that enhance survival and reproduction. However, evolution does not merely propagate favorable traits, nor does it always benefit populations.Life is not fair. A deer grazing contentedly in a field can have her meal cut tragically short by a bolt of lightning. If the doomed doe is one of only three in the population, 1/3 of the population’s gene pool is lost. Random events like this can...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).Mechanisms of Genetic VariationThe original sources of genetic variation are mutations,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...